Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign

Part of paid clinical trials in La Jolla, California.

Sponsor
Scripps Whittier Diabetes Institute
Study ID
NCT03068273
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Real-time CGM data — DEVICE

Study Details

This program will provide patients with type 1 and high risk type 2 diabetes the safest hospitalization by using wireless continuous glucose monitoring devices (CGM) to track their glucose parameters in real-time similar to other continuously monitored vital signs. The CGM will inform a team of health professionals who will monitor the patients' progress, communicate recommendations, and be available for discussion when recommended targets are not achieved. Health teams will utilize sensor results in addition to existing electronic medical records data to evaluate progress and manage care.

Key Dates

Start date
May 31, 2015
Status verified
Sep 2025
Primary completion
Mar 17, 2020
Completion
Mar 17, 2020

Study Design

Enrollment
157 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Intervention
    For type 2 patients in the intervention group, CGM data will be viewed real-time.
  • Experimental: Control
    For type 2 patients in the control group, CGM data is blinded to all and only gathered for comparison purposes to intervention group.

Primary Outcome Measure

Type 2 Diabetes Blood Glucose Time in Range (70-180 mg/dL) [ Time Frame: Up to 30 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
Scripps Whittier Diabetes InstituteLa JollaCalifornia92037-

Find similar trials in La Jolla, CA

By condition
Type 1 diabetesType 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Scripps Whittier Diabetes Institute· La Jolla, CA

Related Studies